SCHEMBL3010983

SCHEMBL3010983

OCCNc1nccs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12824314 0.88 HSD17B10 (0.44)
SCHEMBL14066997 0.83
SCHEMBL2170934 0.79
SCHEMBL11196251 0.79
SCHEMBL4580288 0.79
SCHEMBL14546926 0.79
SCHEMBL622574 0.78 MEN1 (0.45)
SCHEMBL12963710 0.78 SMN1; SMN2 (0.44)
SCHEMBL12181081 0.77 SMN1; SMN2 (0.47)
SCHEMBL5568640 0.76 HRH3 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1951686-B1 QUINAZOLINE DERIVATIVES AS A MULTIPLEX INHIBITOR AND METHOD FOR THE PREPARATION THEREOF HANMI PHARM IND CO LTD (KR) 2013-04-03 EP claimed
US-20080318950-A1 Quinazoline Derivatives as a Multiplex Inhibitor and Method For the Preparation Thereof HANMI PHARM. CO., LTD (KR) 2008-12-25 US claimed
EP-1951686-A1 QUINAZOLINE DERIVATIVES AS A MULTIPLEX INHIBITOR AND METHOD FOR THE PREPARATION THEREOF Hanmi Pharm. Co., Ltd. (KR) 2008-08-06 EP claimed
WO-2007055514-A1 QUINAZOLINE DERIVATIVES AS A MULTIPLEX INHIBITOR AND METHOD FOR THE PREPARATION THEREOF HANMI PHARM. CO., LTD. (KR) 2007-05-18 WO claimed
EP-2185562-B1 PYRROLOPYRIMIDINES USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES JANSSEN PHARMACEUTICA NV (BE) 2015-12-02 EP disclosed
US-8846699-B2 Quinazoline derivatives as a multiplex inhibitor and method for the preparation thereof HANMI PHARM. CO., LTD. (KR) 2014-09-30 US disclosed
EP-1951686-B1 QUINAZOLINE DERIVATIVES AS A MULTIPLEX INHIBITOR AND METHOD FOR THE PREPARATION THEREOF HANMI PHARM IND CO LTD (KR) 2013-04-03 EP disclosed
US-8318731-B2 Pyrrolopyrimidines JANSSEN PHARMACEUTICA NV (BE) 2012-11-27 US disclosed
US-20100204197-A1 PYRROLOPYRIMIDINES JANSSEN PHARMACEUTICA NV (BE) 2010-08-12 US disclosed
EP-2185562-A1 PYRROLOPYRIMIDINES Janssen Pharmaceutica, N.V. (BE) 2010-05-19 EP disclosed
CN-100486985-C 9a-azalides with anti-inflammatory activity ZAMBON SPA (IT) 2009-05-13 CN disclosed
WO-2009016132-A1 PYRROLOPYRIMIDINES JANSSEN PHARMACEUTICA NV (BE) 2009-02-05 WO disclosed
WO-2007055514-A1 QUINAZOLINE DERIVATIVES AS A MULTIPLEX INHIBITOR AND METHOD FOR THE PREPARATION THEREOF HANMI PHARM. CO., LTD. (KR) 2007-05-18 WO disclosed
US-20060166904-A1 9a-azalides with anti-inflammatory activity ZAMBON GROUP S.P.A. (IT) 2006-07-27 US disclosed
EP-1556397-B1 9A-AZALIDES WITH ANTI-INFLAMMATORY ACTIVITY ZAMBON SPA (IT) 2006-03-08 EP disclosed
CN-1708507-A 9 a-azalides with anti-inflammatory activity ZAMBON SPA (IT) 2005-12-14 CN disclosed
EP-1556397-A1 9A-AZALIDES WITH ANTI-INFLAMMATORY ACTIVITY ZAMBON GROUP S.p.A. (IT) 2005-07-27 EP disclosed
WO-2004039821-A1 9A-AZALIDES WITH ANTI-INFLAMMATORY ACTIVITY ZAMBON GROUP S.P.A. (IT) 2004-05-13 WO disclosed
WO-2000044731-A1 NOVEL HYDROXYAMIDINO CARBOXYLATE DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 2000-08-03 WO disclosed
WO-2000026195-A1 NOVEL AMINO ACID HETEROCYCLIC AMIDE DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 2000-05-11 WO disclosed